Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
EBIATLong-Term Debt Issuances
Ratios

Odyssey Health (ODYY) EBIAT (2016 - 2021)

Odyssey Health (ODYY) has 8 years of EBIAT data on record, last reported at -$2.9 million in Q3 2021.

  • For Q3 2021, EBIAT fell 117.76% year-over-year to -$2.9 million; the TTM value through Jul 2021 reached -$16.9 million, down 288.22%, while the annual FY2025 figure was -$1.7 million, 106.89% down from the prior year.
  • EBIAT reached -$2.9 million in Q3 2021 per ODYY's latest filing, up from -$12.4 million in the prior quarter.
  • Across five years, EBIAT topped out at -$31173.0 in Q1 2017 and bottomed at -$23.2 million in Q3 2019.
  • Average EBIAT over 5 years is -$2.4 million, with a median of -$247241.0 recorded in 2018.
  • Peak YoY movement for EBIAT: tumbled 23348.43% in 2019, then surged 94.26% in 2020.
  • A 5-year view of EBIAT shows it stood at -$63408.0 in 2017, then decreased by 9.6% to -$69496.0 in 2018, then crashed by 1938.41% to -$1.4 million in 2019, then skyrocketed by 49.77% to -$711514.0 in 2020, then plummeted by 307.66% to -$2.9 million in 2021.
  • Per Business Quant database, its latest 3 readings for EBIAT were -$2.9 million in Q3 2021, -$12.4 million in Q2 2021, and -$869300.0 in Q1 2021.